Thrombus



Here is a convenient index of articles that have appeared in recent issues of the journal. The article titles are presented, with the keyword given first. Click on any title to find out more about the content.

Article title	Issue

Acute promyelocytic leukaemia, Acute arterial thrombosis in Emma Kalk MRCP Senior House Officer in Haematology; Peter Rose FRCP FRCPATH Consultant Haematologist, Department of Haematology, Warwick Hospital	5.3
Acute stroke, Organised inpatient care for James Kelly BSc MRCP Research Fellow, Anthony Rudd FRCP Consultant Physician and Lead Clinician for Stroke St Thomas’ Hospital, London	6.3
Advanced malignancy, Anticoagulation in Simon Noble MRCP Dip Pall Med PGCE Specialist Registrar, Palliative Medicine, Velindre Hospital, Whitchurch, Cardiff	8.4
Air travel and the risk of thrombosis Sarah Bond MRPharmS MSc Clin Pharm Anticoagulant Specialist Pharmacist, Great Western Hospital, Swindon	10.4
Air travel and venous thrombosis Patrick Kesteven MB BS FRCP FRACP FRCPath PhD Consultant Haematologist; Brian Robinson BSc(Hons) FIBMS DMLM CertEd RGN Haematology Research Nurse, Freeman Hospital, Newcastle-upon-Tyne	3.3
Anti-angiogenic drugs, Thrombosis and Peter Rose, Editor	7.3
Anticoagulant nurses?, What does the future hold for Caroline Baglin RGN Thrombophilia Nurse Specialist, Addenbrooke’s Hospital, Cambridge	9.3
Anticoagulant services – the foundation for clinical governance? Trevor Baglin FRCP FRCPath Consultant Haematologist and Lead Clinician for Clinical Governance, Addenbrooke’s NHS Trust, Cambridge	7.3
Anticoagulants: major advances and patient needs, New Patrick Kesteven MBBS FRCP PhD Consultant Haematologist; Brian Robinson BSc(Hons) FIBMS RGN Anticoagulant Nurse, Freeman Hospital, Newcastle-upon-Tyne	8.1
Anticoagulated patients, Oral vitamin K for excessively Sarah Bond MRPharmS MSc Clin Pharm Anticoagulant Pharmacist; E Sarah Green MA FRCP FRCPath Consultant Haematologist; Sue Rhodes RN; Kirsty Sansum RN; Michelle Taylor RN Anticoagulant Nurse Practitioners, Princess Margaret Hospital, Swindon	6.4
Anticoagulation clinics, Annual review Barry O’Donoghue MBChB Clinical Research Fellow; David Fitzmaurice FRCGP MD Professor of Primary Care Research, Department of Primary Care and General Practice, The Medical School, The University of Birmingham	9.1
Anticoagulation management: The commissioning of anticoagulation management services in primary care Stephen Munday MB BCh FFPHM Director of Public Health, South Warwickshire Primary Care Trust	10.1
Anticoagulation management: Training for anticoagulation management David Fitzmaurice, Editorial Board Member and Director of the National Centre for Anticoagulation Training	10.2
Anticoagulation nurse, Extending the responsibility of the Bunis Packham MA BSc RGN Consultant Nurse (Anticoagulation), and ASA chair, Barnet & Chase Farm Hospitals NHS Trust	7.3
Anticoagulation, Mechanical prostheses and Pushpinder Sidhu FRCSI Specialist Registrar, Cardiothoracic Surgery, Department of Cardiac Surgery, Royal Hospitals Trust, Belfast; Hugh O’Kane FRCS Consultant Cardiac Surgeon, Department of Cardiac Surgery, Royal Hospitals Trust, Belfast	7.1
Antiphospholipid syndrome, Thrombosis and the Beverley J Hunt MD FRCP FRCPath Consultant, Hon Senior Lecturer, Departments of Haematology and Rheumatology, Guy’s and St Thomas’ Trust, London	4.2
Antiplatelet therapy following oral anticoagulant treatment for VTE Peter K MacCallum MD FRCP FRCPath Senior Lecturer and Honorary Consultant Haematologist, Barts and The London, Queen Mary’s School of Medicine and Dentistry, London	6.4
Antiplatelets: Resistance to antiplatelet agents Paul Harrison BSc PhD MRCPath Clinical Scientist and Honorary Lecturer, Oxford Haemophilia Centre and Thrombosis Unit, Churchill Hospital, Oxford	11.3
Aortic tissue valves: aspirin or warfarin? Peter Rose, Editor	9.3

aPL, Managing pregnancy and Beverley J Hunt MD FRCP FRCPath Consultant Haematologist; Cathy Nelson-Piercy MA FRCP Consultant Obstetric Physician; Susan Bewley MRCOG MD MA Consultant Obstetrician; Munther Khamashta MD PhD Consultant Rheumatologist, The Lupus Pregnancy Clinic, Guy’s & St Thomas’ Hospital Trust, London	4.3

Atrial fibrillation in the elderly, Treatment of Dr Will Lester, Haem Specialist Registrar, Department of Haematology, Queen Elizabeth Hospital, Birmingham	4.1

Baker’s cyst?, Deep vein thrombosis or ruptured John Lanham FRCP Consultant Physician and Rheumatologist, Rheumatology Department, Whipps Cross Hospital, London	4.2
Behçet’s disease, Pathology, presentation and treatment of Tony Todd MB ChB MRCP Specialist Registrar in Haematology; Katherine Lowndes MB ChB MRCP Specialist Registrar in Haematology, Department of Haematology, Addenbrooke’s Hospital, Cambridge	9.3
Blood clots – ISTH conference, Birmingham 2003, Beating	7.3
BSH annual meeting, Glasgow 2003 Peter Rose, Editor	7.2
BSH conference: Haematology nursing at the BSH conference, Edinburgh 2006 Michelle Taylor RGN Anticoagulant and Haematology Specialist Nurse, Great Western Hospital, Swindon	10.4
Buerger’s disease: A review of Buerger’s disease Tony Todd MB ChB MRCP Specialist Registrar in Haematology, Addenbrooke’s Hospital, Cambridge	9.2

Calciphylaxis: rarely seen and poorly understood Girish Purohit MRCP BSc Senior House Officer, Haematology, South Warwickshire Hospitals NHS Trust; Jonathan MR Goulding MRCP BSc Specialist Registrar, Dermatology, South Warwickshire Hospitals NHS Trust; Robert Charles-Holmes MD FRCP Consultant Dermatologist, South Warwickshire Hospitals NHS Trust; Peter Rose FRCP FRCPath Consultant Haematologist, South Warwickshire Hospitals NHS Trust; Paneesha Shankaranayana MRCP MRCPath Consultant Haematologist, Heart of England NHS Trust	11.4
Cancer and thromboembolic disease Peter Rose, Editor	5.1
Cancer, Coagulation markers and Peter Rose, Editor	6.4
Cerebral venous thrombosis Damian Wren DM FRCP Consultant Neurologist, Atkinson Morley’s Hospital, Wimbledon	4.1
CHD, Infection as a cause of Amarjit Sethi BSc MRCP Cardiology Research Fellow, The William Harvey Research Institute, London; John C Hogan BSc MD FRCP Consultant Cardiologist; Sandeep Gupta MD MRCP Consultant Cardiologist, Whipps Cross and St Bartholomew’s Hospitals, London	4.3
Clinical nurse specialists and D-dimer assessment of suspected deep vein thrombosis – lessons from Warwick Peter Rose FRCP FRCPath Consultant Haematologist; Susan Poole SRN Clinical Nurse Specialist; Ruth Brown MRCPath Audit Analyst; Supratik Basu MRCP MRCPath Consultant Haematologist; David Clarke FRCR Consultant Radiologist, Warwick Hospital	3.4
Clinical review: Disseminated intravascular coagulation Louise Knowlson MB ChB BSc ST2 in CMT, University Hospital of Coventry and Warwickshire; Katie Randall MB ST3 in Haematology, Queen Elizabeth Hospital, Birmingham	12.4
View references
Clinical review: Intravenous drug use, deep vein thrombosis and anticoagulation Caroline Baglin RGN Thrombophilia Nurse Specialist, Addenbrooke’s Hospital, Cambridge	13.2
Clinical review: Orally active antithrombotic agents: a new era in the prevention of VTE Simon P Frostick MA DM FRCS Professor of Orthopaedics, University of Liverpool	13.1
View references
Clinical review: Pulmonary hypertension secondary to venous thromboembolism Padmaja Lokireddy MBBS MD (Internal Medicine) MRCP(UK) Registrar, Leicester Royal Infirmary; Peter Rose FRCP FRCPath Consultant Haematologist; Anton Borg MD FRCP FRCPath Consultant Haematologist, Warwick General Hospital	13.4
Clinical review: The objectives of the caval filter registry Neil Rane MA MB BChir Specialist Registrar in Radiology, John Radcliffe Hospital, Oxford; Nick Chalmers FRCR Consultant in Interventional Radiology, Manchester Royal Infirmary, Manchester; Raman Uberoi FRCR Consultant in Interventional Radiology, John Radcliffe Hospital, Oxford	13.3
Clinics, Nurse-led thrombophilia Kath Yates PA to Dr O’Shaughnessy – Consultant Haematologist, Southampton General Hospital	5.1
Cocoa as thromboprophylactic agent, Chocolate or aspirin? Louisa Brown MBBS Medical Student; Nichola Biggs MBBS Medical Student; Timothy Farren BSc (Hons) AIBMS Medical Laboratory Scientific Officer; Cedric Ghevaert MD MRCP DipRCPath Specialist Registrar in Haematology; Denise O’Shaughnessy DPhil MBA FRCP FRCPath Consultant Haematologist, Southampton General Hospital, Southampton	7.4
Comment: Assessing dabigatran for atrial fibrillation Peter Rose, Editor	13.3
Comment: Chronic obstructive pulmonary disease Peter Rose, Editor	13.2
Comment: Everything at once Peter Rose, Editor	11.2
Comment: Implementing thromboprophylaxis – the cost Peter Rose, Editor	12.2
Comment: Look and learn David Fitzmaurice FRCGP MD Professor of Primary Care Research, Department of General Practice, The Medical School, Birmingham; Ellen Murray PhD Research Fellow, Department of Primary Care, University of Birmingham	11.3
Comment: Oral anticoagulation for atrial fibrillation Peter Rose, Editor	12.4
View references
Comment: Problems with implementing NPSA alert 18 Peter Rose, Editor	13.1
Comment: The Framingham Heart Study has identified atrial fibrillation (AF) as an independent risk factor for cerebrovascular accidents, even in the absence of mitral valve disease. The relative risk for stroke associated with AF must be of primary consideration, given that oral anticoagulation carries its own risks. The Whitehall study and the British Heart study also found that an increased risk of stroke was associated with AF; however, the relative risks differed somewhat, as did the underlying rate of stroke within the control population. Peter Rose, Editor	13.4
Comment: The new anticoagulants cometh Peter Rose, Editor	12.3
Comment: Thromboprophylaxis for cancer patients Peter Rose, Editor	11.4
Comment: What do readers want? Peter Rose, Editor	6.3
Community DVT management, A pharmacist-led service for Prayna Patel DipCom MRPharmS Anticoagulant Pharmacist and Co-ordinator of inpatient and outpatient anticoagulation treatment and monitoring; John Luckit BSc MRCP MRCPath Haematology Consultant, North Middlesex Hospital, London	5.4
Compression hosiery to prevent post thrombotic syndrome, The use of Patricia Weston RN Thrombosis Nurse Specialist, Addenbrooke’s Hospital NHS Trust, Cambridge	3.4
Congenital atresia of the inferior vena cava and deep vein thrombosis Myles Bradbury MB ChB MRCPCH Specialist Registrar, Department of Haematology, Birmingham Heartlands Hospital, Birmingham	7.1
Consultation: What makes a good consultation? Steve Johnson FRCP FRCPath Consultant Haematologist, Taunton and Somerset Hospital	10.1
Contraception and hormone replacement therapy in thrombophilia Niamh M O’Connell MB MRCPI MRCPath Clinical Research Fellow in Haemostasis; David J Perry MD PhD FRCP FRCPath Senior Lecturer in Haemophilia and Haemostasis, Royal Free Hospital, London	5.4
Coughs, colds and clots Peter Rose, Editor	4.4

D-dimer in deep vein thrombosis, Use of Denise O’Shaughnessy DPhil FRCP FRCPath Consultant Haematologist, Southampton General Hospital, Martin Thomas FRCS Consultant Vascular Surgeon, St Peter’s Hospital, Chertsey	3.2
D-dimer in the diagnosis of DVT, The role of the David Keeling BSc MD MRCP MRCPath Consultant Haematologist, John Radcliffe Hospitals, Oxford	4.2
D-dimer screening tests, The varying clinical efficacy of Peter Rose, Editor	3.4
D-dimer: Harmonisation of D-dimers to predict DVT Chris Gardiner MsC PhD FIBMS Chief Biomedical Scientist, University College Hospital, London	12.2
D-dimer: The role of D-dimer assays in predicting the risk of recurrence of VTE Farooq A Wandroo MBBS MD MRCP MRCPath Consultant Haematologist, Sandwell General Hospital, West Bromwich	10.1
D-dimers: Very high D-dimers – what do they mean? Peter Rose, Editor	9.2
Deep vein thrombosis, Upper limb Kris Bowles MRCP Specialist Registrar in Haematology, Norfolk and Norwich Hospital, Norfolk	5.2
Dental surgery, The anticoagulated patient undergoing Pippa K Blacklock FDSRCS Staff Grade, Department of Oral and Maxillofacial Surgery, Derriford Hospital, Plymouth	7.4
Diagnostics: Should patients with venous thrombosis have cancer screening? Raj K Patel MD MRCP FRCPath Consultant Haematologist, King’s Thrombosis Centre, King’s College Hospital, London	13.1
View references
Diagnostics: The pathogenesis of Lemierre’s syndrome Samreen Siddiq MB BCh MRCP Specialist Registrar in Haematology; Owen Williams PhD MRCP MRCPath Consultant in Microbiology and Infectious Diseases; Andrew Mumford MB ChB PhD MRCP MRCPath Senior Clinical Lecturer in Haematology, Bristol Royal Infirmary	12.4
View references
Diagnostics: Using diagnostic tests David Fitzmaurice MBChB MRCGP MD FRCGP Professor of Primary Care Research, University of Birmingham; Janusz Kaczorowski BA MA PhD Associate Professor of Family Medicine, Univeristy of British Columbia	12.3
Diagnostics: Using the international normalised ratio system in patients with liver disease Anne M Sermon MSc Biomedical Scientist, Department of Coagulation, Northern General Hospital, Sheffield; Steve Kitchen PhD Clinical Scientist, Coagulation Department, Royal Hallamshire Hospital, Sheffield	13.2
View references
Distal DVT: why do we anticoagulate? Peter Rose, Editor	9.4
Dosing – new challenges for the therapeutic management of patients, Anticoagulant computer Peter Rose, Editor	2.4
Dosing in primary care, Validation of a software system for anticoagulant Amjid Riaz MRCGP Clinical Research Fellow; Ellen T Murray MSc Research Fellow; Professor F D Richard Hobbs FRCGP; David A Fitzmaurice MB CHB MRCGP MD Senior Clinical Lecturer, Department of Primary Care and General Practice, The Medical School, University of Birmingham	5.3
Drug interactions in the warfarin clinic, Managing Andrew Radley MPhil MRPharmS MCPP Director of Pharmacy, Perth and Kinross Healthcare NHS Trust	2.4
Drug reactions, The problem of adverse Peter Rose, Editor	8.2
Drug sources – how far should you go?, Informing patients about their Hayley Flavell RGN DPSN BSc Anticoagulant Clinical Nurse Specialist, Russells Hall Hospital, Dudley	8.1
DVT management, A comparison of inpatient and community Roland C Aldridge, 4th Year Medical Student; Osahon A Gbinigie, 4th Year Medical Student; Catherine A Hearnshaw, 4th Year Medical Student; Graham D Johnson, 4th Year Medical Student, University of Birmingham	8.2
DVT: Treating DVT patients in the community Jennie Bailey RGN Anticoagulant Practitioner; Sarah Bond MRPharmS MScClinPharm Specialist Anticoagulant Pharmacist; Sarah Green MA FRCP FRCPath Consultant Haematologist, Great Western Hospital, Swindon	11.1

Experience with anticoagulation therapy, My Edward Bibby, Patient at Shipston Health Centre	4.2

Golden Helix experience, The Carole Connor RGN DN BSc(Hons) DPSN Clinical Nurse Specialist, Birmingham Heartlands and Solihull NHS Trust	3.1
Guidelines: American College of Chest Physicians guidelines on thromboprophylaxis Catherine Bagot MB BS MD MRCP FRCPath Senior Clinical Research Fellow, King’s Thrombosis Centre, King’s College Hospital, Denmark Hill, London	13.2
Guidelines: Anticoagulants – the NPSA’s view Bruce Warner BSc MSc DPharm MRPharmS Senior Pharmacist, National Patient Safety Agency, London	11.2
Guidelines: Responding to thrombosis guidelines Andrew D Blann PhD FRCPath Consultant Clinical Scientist and Senior Lecturer, University Department of Medicine, City Hospital, Birmingham	12.3
Guidelines: Review of NPSA 18 on warfarin dosing Helen Gray MSc MIBMS Specialist Biomedical Scientist, Anticoagulant Department, Stepping Hill Hospital, Stockport	13.3
Guidelines: The 8th ACCP guidelines on thrombosis prevention – core reading for everyone John Pasi MB ChB PhD FRCP FRCPath FRCPCH Professor of Haemostasis and Thrombosis, Barts and The London NHS Trust	13.2
View references
Guidelines: Update on NPSA patient safety alert 18 Rosalind Perrott MRPharmS Senior Anticoagulation and Clinical Thrombosis Pharmacist, King’s College Hospital, London	13.1
View references

Haematomas, Epidurals, heparin and Hugh Antrobus FRCA Consultant, Acute Pain Service, Warwick Hospital	3.2
Haemodialysis, Anticoagulation and RM Higgins MD FRCP Nephrologist, University Hospitals Coventry and Warwickshire, Coventry; M Vegad RCN Dialysis Nurse, University Hospitals Coventry and Warwickshire, Coventry	7.1
Haemostasis link nurse service, Developing a Steve Davidson BSc(Hons) RN DipN Haemostasis and Thrombosis Clinical Nurse, Queen’s Medical Centre, Nottingham	3.3
Haemostasis: Thrombin generation: a global screening test of haemostasis? Roger J Luddington MPhil PhD Principal Clinical Scientist, Haematology Department, Addenbrooke’s Hospital, Cambridge	12.2
Heparin monitoring in pregnancy Caroline Shiach BSc MD FRCP FRCPath Consultant Haematologist, Manchester Royal Infirmary	3.4
Heparins: Are all low molecular weight heparins the same? Shaker Mousa	7.4
Herbal remedies – good or bad companions to anticoagulation therapy? Andrew S Radley MPhil MRPharmS MCPP Lead Principal Pharmacist, NHS Tayside	7.3
Hyperhomocysteineaemia and vascular disease Anne Riddell MSc; Dale Owens PhD; David Perry MD PhD FRCP FRCPath Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free Hospital, London	2.4

ICT meeting – Slovenia 2004, Focus on Sarah Bond MRPharmS Dip Clin Pharm; Michelle Taylor RN Anticoagulant Practitioners, Great Western Hospital, Swindon, Wiltshire	8.3
Imaging modalities to investigate DVT and PE Nick Screaton FRCR MRCP Fellow in Cardiothoracic Radiology, Papworth Hospital, Cambridgeshire	4.4
Imaging: The role of MRI in thrombosis diagnosis Sharon Zahra MD DCH MRCPCH DipRCPath Haematology Department, Addenbrooke’s Hospital, Cambridge	11.4
Inferior vena caval filters: current concepts Hasan I Hasan MRCP FRCR Specialist Registrar in Radiology Matthew B Matson MRCP FRCR Consultant Vascular and Interventional Radiologist, Royal London Hospital	10.2
Information, Centralising thrombophilia patient Steve Davidson BSc (Hons) RN DipN Haemostasis & Thrombosis Clinical Nurse, Queen’s Medical Centre, Nottingham	4.3
Inpatient warfarin dosage, Nurse-led management of Fran Pressley EN(G), RGN, MISM, Cert/Ed Anticoagulant Nurse Specialist, Royal Gwent Hospital, Cardiff Road, Newport, Gwent	8.4
INR measurement – a review of three systems, Near-patient E T Murray MSc Research Fellow; David Fitzmaurice MRCGP Senior Lecturer, Department of General Practice, The Medical School, Birmingham	3.3
INR: Update on point-of-care devices for international normalised ratio testing Ellen Murray PhD Research Fellow, Department of Primary Care, University of Birmingham; Ian Jennings PhD CSci FIBMS Scientific Programme Manager, UK National External Quality Assessment Scheme for Blood Coagulation, Sheffield	12.2
Interaction between cranberry juice and warfarin – fact or fiction? Peter Rose, Editor	8.3
Investigation: Herbal medicine and oral anticoagulants Sarah Bond MRPharmS MSCClin Pharm Specialist Anticoagulant Pharmacist; E Sarah Green MA FRCP FRCPath Consultant Haematologist; Lyn Williamson MA FRCP Consultant Rheumatologist, Great Western Hospital, Swindon	11.2
Investigation: Transfusion issues surrounding the use of fresh frozen plasma Barry Hill CSci FIBMS Chief Biomedical Scientist, Blood Transfusion Department, Wigan Royal Infirmary	12.3
Ischaemic heart disease, Antiplatelet agents and Sarah L Allford MA MRCP Haematology Research Fellow, University College Hospital, London	5.1

JAK2 mutation: a thrombotic risk factor? Peter Rose, Editor	10.3
JAK2 mutation: Role of the JAK2 mutation in abdominal vein thrombosis Catherine N Bagot MD MRCP Specialist Registrar in Haematology; Raj K Patel MD MRCP MRCPath Consultant Haematologist; Roopen Arya MA PhD FRCP FRCPath Consultant Haematologist, King’s College Hospital, London	11.3

Laboratory tests: why do we need them? Peter Rose, Editor	4.3
Leeches prevent HUS?, Can Peter Rose, Editor	8.4
LMWH: PE and the benefits of LMWH Marion Delcroix MD PhD Pneumology Department, University Hospital Leuven, Belgium; Member of the Pulmonary Vascular Pathology Task Force of the Belgian Society of Pneumology	10.4
LMWHs: Bleeding risk of LMWHs used at therapeutic dose in the elderly Isabelle Gouin-Thibault PhD; Virginie Siguret PhD Laboratoire d’Hématologie; Eric Pautas MD Médecine Interne, Gériatrie, Hôpital Charles Foix (University Hospital of Paris), Ivry/Seine, France	9.2
LMWHs: Low molecular weight heparin in pregnancy: is dose frequency relevant? Mark P Smith MBChB FRACP FRCPA Consultant Haematologist, Canterbury District Health Board, Christchurch, New Zealand	10.1
LMWHs: Use of low molecular weight heparins in the long-term treatment of VTE Marios E Daskalopoulos MD MSc DIC Consultant Vascular Surgeon, Department of Vascular Surgery, First Hospital of Athens, Greece; Christos D Liapis MD FACS FRCS Director, Department of Vascular Surgery, University of Athens, Greece	10.2
Long-haul flights: risk factors for VTE Kirsty Sansum RN Anticoagulant Nurse Practitioner; E Sarah Green MA FRCP FRCPath Consultant Haematologist; Sarah Bond MRPharmS MSc Clin Pharm Anticoagulant Pharmacist; Sue Rhodes RN Anticoagulant Nurse Practitioner; Michelle Taylor RN Anticoagulant Nurse Practitioner, Princess Margaret Hospital, Swindon	6.2

Malignancy – a varied approach, Venous thromboembolic events and Myles Bradbury MRCPCH Specialist Registrar Haematology, City Hospital, Birmingham	7.4
Malignancy: Venous thromboembolism and malignancy Tina Biss BMedSci BM BS MRCP DipRCPath Specialist Registrar in Haematology; John Hanley MBChB MD MRCPath FRCP Consultant Haematologist, Newcastle-upon-Tyne Hospitals NHS Trust	10.3
Managing retinal vein thrombosis: a visionary approach Denise O’Shaughnessy DPhil MBA FRCP FRCPath Consultant Haematologist; Iain Chisholm MB Camb. BChir MA Camb. FRCS Eng. FRCOphth DO Eng. Consultant Ophthalmologist, Southampton University Hospitals Trust	6.3
Mediterranean diet and statins, The benefits of a Sarah H Wild PhD MRCP MRCGP MFPHM Lecturer in Public Health Medicine, Health Care Research Unit; Christopher D Byrne PhD MRCPath FRCP Professor of Endocrinology & Metabolism, Director Wellcome Trust Clinical Research Facility, Honorary Consultant Physician, University of Southampton School of Medicine, Southampton General Hospital	5.2
Meeting report: British Thoracic Society winter meeting 2005 Keith Rhodes Independent medical writer	9.4
Meeting report: Report from the 21st ISTH Congress Tim Farren BSc(Hons) MIBMS Clinical Scientist (Grade A) and BMS Practitioner, Barts and The London NHS Trust; Celestine O’Shaughnessy PhD Scientific Advisor; Denise O’Shaughnessy FCRP FCRPath Senior Medical Advisor, Blood Policy Unit, Department of Health	11.4
Mesenteric vein thrombosis Denis J O’Keeffe MB BCH MRCPI Haematology Specialist Registrar, Addenbrooke’s Hospital, Cambridge	7.2
Multidisciplinary management of VTE Peter Rose FRCP FRCPath Consultant Haematologist, Department of Haematology; Grace O’Hare Clinical Nurse Specialist, Department of Haematology, Warwick Hospital	12.4
View references

Near-patient testing in oral anticoagulation therapy Barry Hill FIBMS Chief Biomedical Scientist Blood Transfusion Department, Wigan Royal Infirmary, Wigan	5.4
Nephrotic syndrome: Thrombotic complications of nephrotic syndrome Elaine C Jolly BSc(Hons) MBChB(Hons) MRCP Specialist Registrar in Nephrology, Addenbrooke’s Hospital, Cambridge	10.3
New drugs in the NHS, Affording Christopher Newdick BA, CNAA, LLM (London) Barrister, Reader in Health Law, University of Reading; Consultant to Reading PCT and Member of the Berkshire Priorities Committee	8.4
NICE guidance on atrial fibrillation David Fitzmaurice FRCGP MD Professor of Primary Care Research, Department of General Practice, The Medical School, Birmingham	12.1
Non-compliance: Non-compliance in patients on long-term oral anticoagulation treatment Teresa Tripp RN BSc Anticoagulation Clinical Nurse Specialist, John Radcliffe Hospital, Oxford	9.4
Nursing symposium of the British Society for Haemostasis and Thrombosis Ellen Murray PhD Research Fellow, University of Birmingham; Caroline Baglin RGN Nurse Specialist, Addenbrooke’s Hospital, Cambridge	12.1

Obesity: Obesity and clots Peter Rose, Editor	11.1
Obesity: Obesity and venous thromboembolism Vikramajit Singh MRCP Specialist Registrar (LAT) in Haematology, Christie Hospital, Manchester; Paneesha Shankaranarayana MRCP MRCPath Clinical Research Fellow in Haematology; Peter Rose FRCP FRCPath Consultant Haematologist, Warwick Hospital, Warwick	11.3
Oral anticoagulant management study day, The clinical impact of attendance at an David A Fitzmaurice MB ChB MRCGP MD Senior Clinical Lecture; Ellen T Murray MSc Research Fellow; Pat Marsh RGN; Kirsten M Gee BNurs, Department of Primary Care and General Practice, The Medical School, University of Birmingham	5.3
Oral anticoagulation, Guidelines for patient self-testing and self-management of Deborah McCahon BSc MSc Research Associate; Ellen Murray RGN MSc Research Fellow and Practice Nurse; David Fitzmaurice MBChB MRCGP MD Professor in Primary Care Research and GP, Department of Primary Care and General Practice, The Medical School, The University of Birmingham, Edgbaston	8.1
Oral contraception, HRT and venous thromboembolism Karen Murphy MB BCh BAO MRCPI MRCPath; W C Yoong MRCOG; D J Perry MD PhD FRCP FRCPath Katherine Dormandy Haemophilia Centre and Haemostasis Unit, Royal Free Hospital, London	3.1
Orthopaedic surgery, Thromboprophylaxis in David Warwick MD FRCS FRCS(Orth) Consultant Orthopaedic Surgeon, Southampton University Hospitals NHS Trust	4.2
Osteochondroma: A case of DVT in a 13-year-old girl with osteochondroma Sarah Bond MRPharmS MSc Clin Pharm Anticoagulant Specialist Pharmacist, Great Western Hospital, Swindon	10.4
Osteoporosis, Anticoagulation and Sandra Young Min BSc(Hons) MRCP MRCPath Specialist Registrar in Haematology, Birmingham Children’s Hospital, Birmingham	5.1
Outpatient management of DVT, Nurse-led Lindsey Murray RGN Clinical Nurse Practitioner, Acute Medical Services, Western General Hospital, Edinburgh	3.2
Outpatient treatment of DVT: time for a change? Davina Gallagher RGN Anticoagulant Specialist Nurse; Abdul Shlebak MD FRCP MRCPATH Consultant Haematologist, St Mary’s Hospital, London	5.3
Outreach service – a viable alternative to hospitalisation, An anticoagulant Carole Connor RGN DN PgDip BSc (Hons) DPSN Senior Lecturer, Coventry University	4.1
Ovarian stimulation: IJV thrombosis and ovarian stimulation Jhansi Mudanna MRCP Specialist Registrar in Haematology; Shankara Paneesha MD MRCP MRCPath Clinical Research Fellow; Peter Rose FRCP FRCPATH Consultant Haematologist, Warwick Hospital	10.3

Palliative care, Anticoagulation in Carina Saxby MRCGP Specialist Registrar in Palliative Medicine, St Catherine’s Hospice, Scarborough	7.1
Patient management: Establishing an outpatient pulmonary embolism service Ann J Davenport RN RM Lead Thrombosis Nurse Specialist, Thrombosis Treatment Team, Addenbrooke’s Hospital, Cambridge	13.3
Patient management: Mechanical thromboprophylaxis Lynda Bonner RGN Clinical Nurse Specialist, King’s College Hospital, London	13.4
Patient management: Prevention of VTE in hospitalised patients – the CMO’s report Roopen Arya MA PhD FRCP FRCPath Consultant Haematologist, King’s College Hospital, London	11.2
Patient management: Self-management of oral anticoagulation and quality assurance Ellen Murray PhD Research Fellow, Department of Primary Care, University of Birmingham; Ian Jennings PhD CSci FIBMS Scientific Programme Manager, UK National External Quality Assessment Service; David Fitzmaurice MBChB MRCGP MD FRCGP	13.1
View references
Patient management: Why use computerised decision support software? David Fitzmaurice MBChB MRCGP MD FRCGP Professor of Primary Care Research, University of Birmingham	12.4
Patient self-testing: Guidelines for patient self-testing and management of oral anticoagulation David Fitzmaurice FRCGP MD Professor of Primary Care Research, The Medical School, University of Birmingham	9.4
Pharmacist-led service for inpatient anticoagulation, A Prayna Patel DipCom MRPharmS Anticoagulant Pharmacist and Co-ordinator of inpatient and outpatient anticoagulation treatment and monitoring; John Luckit BSc MRCP MRCPath Haematology Consultant, North Middlesex Hospital, London	6.1
Phlebotomy – a service for vulnerable patients, Community Caroline Shiach BSc MD FRCP FRCPath Consultant Haematologist; Jeanne Birchenhall RGN DMS Anticoagulant Nurse Specialist, Manchester Royal Infirmary	3.2
Planning an international normalised ratio testing service Phil Carson FIBMS DMS MSc CSci Clinical Scientist, Haematology Department, Royal Cornwall Hospitals Trust, Truro	12.1
Plasma D-dimers, Exclusionary testing – James Kelly MRCP Research Fellow; Beverley J Hunt MD Consultant, Department of Haematology, Guy’s & St Thomas’ Trust	6.4
Platelet products, The bacterial contamination of Barry Hill FIBMS Chief Biomedical Scientist, Blood Transfusion Department, Wigan Royal Infirmary	5.2
PNH and PV, Thrombosis in Peter Rose, Editor	7.4
Polycythaemia vera and portal vein thrombosis David Jackson MBBS BSc(Med) FRACP FRCPA Senior Haematology Registrar, Addenbrooke’s Hospital, Cambridge	8.3
Post-thrombotic syndrome Robert Weinkove MA MRCP Specialist Registrar in Haematology, Department of Haematology, Darent Valley Hospital, Dartford; Savita Rangarajan MRCP MRCPath Consultant Haematologist, The Centre for Haemostasis and Thrombosis, St Thomas’ Hospital, London	9.3
Post-thrombotic syndrome: aetiology and prevention Kevin Varty MD FRCS Consultant Vascular Surgeon, Addenbrooke’s NHS Trust, Cambridge	6.1
Pregnancy, Anticoagulant issues in Peter Rose, Editor	6.1
Pregnancy, The use of low molecular weight heparin in Rachel Hall BSc MBBS MRCP MRCPath Consultant Haematologist, Royal Bournemouth Hospital, Bournemouth; Denise O’Shaughnessy DPhil MBA FRCP FRCPath Consultant Haematologist, Southampton University Hospitals Trust, Southampton	7.2
Pregnancy: Thrombophilia and foetal loss AJ Rai BSc MRCOG Lecturer; Lesley Regan MD FRCOG Professor, Department of Obstetrics and Gynaecology, Imperial College School of Medicine at St Mary’s, London	2.4
Pre-test probability scoring: The validity of pre-test probability scoring to predict PE in routine practice P Jayne Norcliffe MRCP Specialist Registrar, Churchill Hospital, Oxford; Christopher WH Davies MD FRCP Consultant Physician, Royal Berkshire and Battle Hospitals NHS Trust, Reading	10.2
Primary (essential) thrombocythaemia, Thrombo-haemorrhagic complications in David Bareford MD FRCP FRCPath Consultant Haematologist, Russells Hall Hospital, Dudley, West Midlands	9.1
Primary care anticoagulation management, A review of David Fitzmaurice MD Senior Lecturer; Ellen Murray SRN MHS Research Fellow, Department of General Practice, The Medical School, The University of Birmingham; Jim Murray FRCP FRCPath Consultant Haematologist, University Hospital NHS Trust Birmingham	4.3
Primary care case, DVT treatment – the David Fitzmaurice MRCGP Senior Lecturer, Department of General Practice, The Medical School, Birmingham	3.3
Primary care management of deep venous thrombosis David A Fitzmaurice MD Senior Lecturer; Ellen T Murray MSc Research Fellow; FD Richard Hobbs MB ChB FRCGP Professor Department of Primary Care and General Practice, The Medical School, University of Birmingham, Edgbaston; Peter E Rose FRCP FRCPATH Consultant Haematologist, Warwick Hospital	4.4
Primary care, DVTs and Rod Smith MA MB BChir MRCGP Clinical Governance Head, Reading Thames Primary Care Group	3.4
Prothrombin?, What’s the problem with Peter Rose, Editor	4.1
Pulmonary embolism and the use of D-dimer and pre-test probability Denise O’Shaughnessy DPhil MRCP MRCPath Consultant Haematologist, Southampton General Hospital. Formerly at St Peter’s Hospital, Chertsey, where these data originate, Jon Miles MD MRCP Consultant Chest Physician, North Manchester General Hospital	3.1
Pulmonary embolism: The outpatient management of pulmonary embolism Christopher Davies MD FRCP Consultant Respiratory Physician, Department of Respiratory Medicine, Royal Berkshire and Battle NHS Hospitals Trust, Reading	9.2

Recombinant VIIa – the universal haemostatic agent? Eric J Watts DM FRCP FRCPath Basildon Hospital, Nethermayne, Basildon	7.2
Recurrent DVT: A problem of recurrent DVT despite adequate treatment with warfarin Sarah Bond MRPharmS MScClinPharm Specialist Anticoagulant Pharmacist, Great Western Hospital, Swindon	10.2
Research and development: The new oral anticoagulants Chee W Khoo MRCP Research Fellow; Kok-Hoon Tay MRCP Research Fellow; Eduard Shantsila MD Research Fellow; Gregory YH Lip MD FRCP Professor of Cardiovascular Medicine, University of Birmingham Centre for Cardiovascular Science, City Hospital, Birmingham	13.3
Results by voicemail, Anticoagulant Paul L Cervi MRCPI FRCPath Consultant Haematologist; Robert Duck, IT Manager, Basildon & Thurrock NHS Trust, Nether Mayne, Basildon, Essex	5.1
Risk analysis: Developing a national risk assessment model to prevent VTE in hospital Trevor Baglin MA MB ChB PhD FRCP FRCPath Consultant Haematologist, Cambridge University Hospitals NHS Trust	13.1
View references
Risk assessment: Coagulation parameters: overview and changes in patients with pre-eclampsia Chris Gardiner PhD MSc FIBMS Nuffield Department of Obstetrics and Gynaecology, University of Oxford	13.4
Role of the clinical nurse specialist, The developing Caroline Baglin RGN Thrombophilia Nurse Specialist, Department of Haematology, Addenbrooke’s Hospital, Cambridge	4.4

Screen?, To screen or not to Peter Rose, Editor	3.1
Secondary care, Management of DVT – Peter Rose, Editor	3.2
Service for the 21st century, An anticoagulant Paul Stross MB Chb MRCP MRCPath Consultant Haematologist, St Richard’s Hospital, Chichester	4.4
Service in evolution, An anticoagulation Michelle Taylor RN; Sue Rhodes RN; Sarah Bond MRPharmS MSc Clin Pharm; Kirsty Sansum RN Anticoagulant Practitioners; E Sarah Green MA FRCP FRCPath, Consultant Haematologist Anticoagulant Service, Department of Haematology, Princess Margaret Hospital, Swindon	5.4
Services: exercising accountability, Nurse-led anticoagulant Fiona Dobson MSc RN RNT Head of Continuing Professional Development, Queen’s Medical Centre, Nottingham	7.2
Sickle cell disease, Thrombosis in Antonio Almeida MRCP Specialist Registrar; Sally Davies FRCP FRCPath Consultant Haematologist, Central Middlesex Hospital, London	3.3
Strokes, Preventing recurrent Peter Rose, Editor	6.2
Superwarfarins, Beware the Malcolm Tait FCPATH (Haem) SA Haematologist, University Hospitals, Warwick and Coventry	7.4
Surgery and thromboprophylaxis: where now?, Orthopaedic Peter Rose, Editor	4.2
Surgical procedures: Perioperative warfarin management Carol Arbuthnot MBChB MRCP MRCPath Specialist Registrar in Haematology; Will Lester MBChB MRCP MRCPath Consultant Haematologist, University Hospital Birmingham	11.2
Systemic lupus erythematosis, Thrombosis and Peter Rose, Editor	5.3

TEG testing during surgery Barry Hill CSci FIBMS Chief Biomedical Scientist, Blood Transfusion Dept, Wigan Royal Infirmary	8.3
Thalidomide in myeloma: Thrombogenecity of thalidomide in myeloma Mahesh Kumar MBBS Haematology Senior House Officer, University Hospitals Coventry and Warwickshire; Shankaranarayana Paneesha MD MRCP MRCPath Haematology Clinical Research Fellow, Warwick Hospital; Anton Borg MD MRCP MRCPath Consultant Haematologist, Warwick Hospital	9.4
The design and implementation of protocols for venous thromboembolism Paul Harrison MBBS FRCP FRCPath Consultant Haematologist, Dudley Group of Hospitals NHS Trust	12.1
The SMART study: Self-management of oral anticoagulation: the SMART study David Fitzmaurice FRCGP MD Professor of Primary Care Research, The Medical School, University of Birmingham	10.4
The WRIGHT project: update Patrick Kesteven MBBS FRACP FRCP FRCPath PhD Consultant Haematologist, Freeman Hospital, Newcastle-upon-Tyne	12.1
Therapeutic agents and venous thromboembolic disease, Examining the links between Peter Rose, Editor	5.2
Therapeutics: The use of thrombolysis for the treatment of pulmonary embolism David A Fitzmaurice MD FRCGP Professor of Primary Care, Primary Care Clinical Sciences, University of Birmingham	13.2
Therapeutics: Thrombolysis-related haemorrhage: anticoagulant and antiplatelet therapy Elizabeth A Warburton MA MBBS DM MRCP Consultant in Stroke Medicine, Department of Clinical Neurosciences, Cambridge University, NHS Foundation Trust, Cambridge; Philip L Clatworthy MB/BChir MA MRCP MRC Training Fellow, Department of Clinical Neurosciences, Cambridge University, NHS Foundation Trust, Cambridge	12.3
Therapeutics: What will be the role of warfarin in atrial fibrillation in the future? David A Fitzmaurice MD FRCGP Professor of Primary Care, Primary Care Clinical Sciences, University of Birmingham	13.4
Thrombocytopenia in pregnancy, The management of Adrian Copplestone FRCP FRCPath Consultant Haematologist, Derriford Hospital, Plymouth	6.3
Thrombocytopenia, Heparin-induced skin necrosis as a manifestation of Adam Ashley MB ChB FRCS Senior House Officer, Department of Surgery; Richard Murrin BSc MBChB MRCP MRCPath Consultant Haematologist, Department of Haematology, Sandwell General Hospital, West Bromwich, West Midlands	9.1
Thrombocytopenia, Investigation of Tobias Menne Cert State Exam (Berlin) MRCP Specialist Registrar in Haematology, Addenbrooke’s Hospital, Cambridge; Gillian Evans MRCP MRCPath Consultant Haematologist, Haemophilia Centre, Kent and Canterbury Hospital, Kent	6.2
Thromboembolic disease – time for a review of clinical practice? Derek Bell MD FRCP Chest Physician, Edinburgh Royal Infirmary	5.2
Thromboembolic disease: paradoxical increased risk of thrombosis after initiation of oral anticoagulation Habib Rehman FRCPI Consultant Physician, Broomfield Hospital, Chelmsford, Essex	9.1
Thromboembolism in pregnancy – BCOG, Glasgow 2004, Fighting Shari Barber, Independent Medical Writer	8.2
Thromboembolism: Antenatal venous thromboembolism Jenny Voke MBBS FRCPath Consultant Haematologist, East and North Hertfordshire NHS Trust and Luton and Dunstable Hospital NHS Trust	9.2
Thrombophilia, Talking to your patients about Caroline Baglin RGN Thrombophilia Nurse Specialist, Addenbrooke’s NHS Trust, Cambridge	6.3
Thromboprophylaxis in pregnancy Peter Rose, Editor	12.1
Thromboprophylaxis: Thromboprophylaxis after orthopaedic surgery David Camilleri Specialist Registrar, Department of Haematology, Addenbrooke’s Hospital, Cambridge	11.1
Thrombosis in children Part 1: incidence, risk factors and diagnosis Elene Psiachou-Leonard MRCP (I) MRCPCH Consultant Paediatric Haematologist, University Hospitals of Leicester NHS Trust; Denise O’Shaughnessy FRCP FRCPath DPhil MBA Consultant Haematologist, Senior Medical Officer, Blood Policy Unit, Department of Health, London	8.1
Thrombosis in children Part 2: therapeutic options Elene Psiachou-Leonard MRCP(I) MRCPCH FGHA Consultant Paediatric Haematologist, Children’s Hospital, Leicester Royal Infirmary; Denise O’Shaughnessy FRCP FRCPath DPhil MBA Consultant Haematologist, Senior Medical Officer, Blood Policy Unit, Department of Health, London	8.2
Thrombosis: Predicting the recurrence of thrombosis Ian Jennings PhD CSci FIBMS Scientific Programme Manager, UK National External Quality Assessment Scheme for Blood Coagulation, Sheffield	11.3
Tinzaparin for thromboprophylaxis and treatment during pregnancy Mark P Smith MBChB FRACP FRCPA, Consultant Haematologist, Canterbury Health Laboratories, Christchurch, New Zealand	8.3
Training: a review, Oral anticoagulation management Tricia Henley, Short Course Co-ordinator, The Medical School, University of Birmingham	6.1
Tramadol and warfarin, Interaction between Andrew J McGuire BSc MRPharmS Practice Pharmacist; David S. Binnie MB ChB MRCGP General Practitioner, Lagmhor Surgery, Perthshire	4.1
Travel and thrombosis: advice to patients Caroline Baglin RGN Thrombophilia clinical nurse specialist, Addenbrooke’s NHS Trust, Cambridge	8.2

Ultrasound scanning, Access for GPs to Doppler Karl Johnson MRCP FRCR Consultant Radiologist, Birmingham Children’s Hospital; Thomas Goodfellow MRCP FRCR Consultant Radiologist, Walsgrave Hospital, Coventry; Richard Wellings MRCP FRCR Consultant Radiologist, Walsgrave Hospital, Coventry	2.4

Venometer – assessing its potential for cost and bed-day savings, The Brian Robinson FIBMS DMLM BSc RGN Haematology Research Nurse; Fiona Holmes SRN Sister, Emergency Admission Ward; Patrick J L Kesteven MB BS FRACP FRCP FRCPath PhD Consultant Haematologist; Simon Elliott MBChB FRCR Consultant Radiologist, The Freeman Hospital, Newcastle upon Tyne	3.1
Veno-occlusive disease following stem cell transplantation, Hepatic Premini Mahendra MD MRCP MRCPath Consultant Haematologist, Bone Marrow Transplant Unit, University Hospital Birmingham NHS Trust	3.2
Venous thromboembolism and acute medical illness KK Hampton MD Senior Lecturer and Consultant Haematologist, Division of Genomic Medicine, Royal Hallamshire Hospital, Sheffield; Richard Hobbs FRCP FRCGP Professor and Head of Primary Care and General Practice, University of Birmingham	6.2
Venous thrombosis, Ethnic communities and Raj K Patel MRCP MRCPath Consultant Haematologist; Roopen Arya FRCP PhD Consultant Haematologist, Department of Haematological Medicine, King’s College Hospital, London	8.4
Verotoxin unmasked Peter Rose, Editor	5.4
Von Willebrand factors high on meeting agenda Denise O’Shaughnessy MRCP MRCPath Consultant Haematologist, Southampton University Hospitals Trust	4.2
VQ scan for diagnosis of pulmonary embolism, Clinicians’ use of the Paul Beckett MB BChir MRCP Consultant Respiratory Physician; Sutapa Biswas MB BS Senior House Officer, Queen’s Hospital, Burton-on-Trent	9.3
VTE – a greater danger than MRSA Peter Rose, Editor	9.1
VTE, The combined pill and Anne Szarewski MBBS DRCOG PhD MFFP Clinical Consultant, Cancer Research UK; Senior Clinical Medical Officer, Margaret Pyke Centre, London	6.4
VTE: The burden of venous thromboembolic disease in medical patients Victoria Drought BA MRCP Specialist Registrar; David Parr MA MD MRCP Consultant Respiratory Physician, University Hospitals Coventry and Warwickshire NHS Trust	12.2
VTE: UK outpatient VTE outcomes Denise O’Shaughnessy FCRP FCRPath, Senior Medical Advisor; Celestine O’Shaughnessy PhD Scientific Advisor, Blood Policy Unit, Department of Health	11.4

Warfarin dosage, Customised Peter Rose, Editor	7.1
Warfarin dosing: Warfarin dosing algorithm based on genetic and environmental factors Farhad Kamali BSc PhD FBPharmacolS Professor of Clinical Pharmacology, University of Newcastle-upon-Tyne	10.3
Warfarin for patients with atrial fibrillationwarfarin for patients with atrial fibrillation, The real cost of Peter Rose, Editor	8.1
Warfarin initiation, Nomograms for Andrew Radley MPhil MCPP MRPharmS Principal Pharmacist, Tayside NHS Trust	6.2
Warfarin resistance: The mechanisms and management of warfarin resistance Andrew D Mumford MB ChB MRCP MRCPath PhD Consultant Senior Lecturer, United Bristol Healthcare Trust; Dominic J Harrington MIQA MSc PhD Principal Clinical Scientist and Honorary Senior Lecturer; Martin J Shearer MRCPath PhD Principal Scientist and Honorary Senior Lecturer, The Centre for Haemostasis and Thrombosis, St Thomas' Hospital, London	11.1
Warfarin therapy, Reversing the effects of Henry G Watson MD MRC Path FRCP Consultant Haematologist, Aberdeen Royal Infirmary, Aberdeen	6.1

Ximelagatran: Lament for ximelagatran David Fitzmaurice, Editorial Board Member, and Peter Rose, Editor	10.1

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.
Copyright (©) 2010 Hayward Group Ltd. The title Thrombus is the property of Hayward Group Ltd and, together with the content, is bound by copyright. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk